Literature DB >> 16203155

Synthesis and biological evaluation of novel lipid A antagonists.

Francesco Peri1, Chiara Marinzi, Marek Barath, Francesca Granucci, Matteo Urbano, Francesco Nicotra.   

Abstract

A mimetic of Lipid A with a beta-N(OMe) glycosidic linkage, four linear C-14 hydrophobic chains and without phosphate groups has been prepared together with its beta-O-linked analogue. Both these molecules were active in inhibiting the inflammatory action of Escherichia coli lipid A on MT2 macrophages in a dose-dependent manner, while they were completely devoid of inflammatory activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16203155     DOI: 10.1016/j.bmc.2005.08.047

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

1.  A synthetic lipid A mimetic modulates human TLR4 activity.

Authors:  Matteo Piazza; Valentina Calabrese; Gaetana Damore; Roberto Cighetti; Theresa Gioannini; Jerrold Weiss; Francesco Peri
Journal:  ChemMedChem       Date:  2011-12-02       Impact factor: 3.466

Review 2.  Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues.

Authors:  Aileen F B White; Alexei V Demchenko
Journal:  Adv Carbohydr Chem Biochem       Date:  2014       Impact factor: 12.200

3.  Synthesis of anti-inflammatory α-and β-linked acetamidopyranosides as inhibitors of toll-like receptor 4 (TLR4).

Authors:  Peter Wipf; Benjamin R Eyer; Yukihiro Yamaguchi; Feng Zhang; Matthew D Neal; Chhinder P Sodhi; Misty Good; Maria Branca; Thomas Prindle; Peng Lu; Jeffrey L Brodsky; David J Hackam
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

4.  Agonistic and antagonistic properties of a Rhizobium sin-1 lipid A modified by an ether-linked lipid.

Authors:  Mahalakshmi Vasan; Margreet A Wolfert; Geert-Jan Boons
Journal:  Org Biomol Chem       Date:  2007-05-29       Impact factor: 3.876

5.  Neoglycosylation and neoglycorandomization: Enabling tools for the discovery of novel glycosylated bioactive probes and early stage leads.

Authors:  Randal D Goff; Jon S Thorson
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.